A promising new therapy, the FDA approval of Lipfendra, and updated cholesterol guidelines are expanding treatment options ...

Updated cholesterol guidelines could make more than half of adults ages 30 to 79 in the United States eligible for statins.

U.S. cholesterol guidelines have evolved to evaluate heart risk throughout a person's life, enabling more adults—particularly ...

Scientists have identified an immune response that may explain why statins cause muscle pain, weakness, and exercise ...

How to lower your cholesterol naturally with plant-based foods, fiber, healthy fats, exercise, and smart habits—plus, when ...

A twice-yearly inclisiran injection helped more high-risk patients reach LDL cholesterol goals in a major clinical trial.

A new FDA-approved cholesterol drug replaces injectable treatments with a daily pill—and experts say it delivers powerful results.

Recently, the FDA has approved an oral PCSK9 inhibitor, Lipfendra, for the treatment of high cholesterol. A cardiologist ...

Statins are one of the most well-known medications prescribed to control cholesterol. Most heart disease patients are told to ...

Scientists created a tool to help doctors predict a patient’s risk of severe muscle problems from taking a statin.

High cholesterol is one of the major risk factors for heart disease and stroke. While statins have been the most common treatment for high cholesterol for seve ...

In an observational study, statin use was associated with slower cognitive decline in women with Alzheimer’s disease and elevated low-density lipoprotein cholesterol.